  Modern drug discovery is often time-consuming, complex and cost-ineffective
due to the large volume of molecular data and complicated molecular properties.
Recently, machine learning algorithms have shown promising results in virtual
screening of automated drug discovery by predicting molecular properties. While
emerging learning methods such as graph neural networks and recurrent neural
networks exhibit high accuracy, they are also notoriously computation-intensive
and memory-intensive with operations such as feature embeddings or deep
convolutions. In this paper, we propose a viable alternative to existing
learning methods by presenting MoleHD, a method based on brain-inspired
hyperdimensional computing (HDC) for molecular property prediction. We develop
HDC encoders to project SMILES representation of a molecule into
high-dimensional vectors that are used for HDC training and inference. We
perform an extensive evaluation using 29 classification tasks from 3
widely-used molecule datasets (Clintox, BBBP, SIDER) under three splits methods
(random, scaffold, and stratified). By an comprehensive comparison with 8
existing learning models including SOTA graph/recurrent neural networks, we
show that MoleHD is able to achieve highest ROC-AUC score on random and
scaffold splits on average across 3 datasets and achieve second-highest on
stratified split. Importantly, MoleHD achieves such performance with
significantly reduced computing cost and training efforts. To the best of our
knowledge, this is the first HDC-based method for drug discovery. The promising
results presented in this paper can potentially lead to a novel path in drug
discovery research.
